NCT06371274 2025-08-12
A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.
First Affiliated Hospital of Zhejiang University
Phase NA Recruiting
Clinical Trials
9 trialsNCT06028672 2025-02-06
TA56
Peking Union Medical College Hospital
Phase NA Recruiting
NCT06709274 2024-11-29
MOTION-NSCLC
Guangdong Association of Clinical Trials
Phase NA Not yet recruiting
NCT06256224 2024-04-24
Toripalimab Combined With Definitive CCRT for LACC Patients
Ruijin Hospital
Phase NA Recruiting
NCT05877573 2023-07-05
Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal Cancer
Nanfang Hospital, Southern Medical University
Phase NA Recruiting
NCT05478473 2023-06-18
Clinical Study of Chidamide Combined With Toripalimab in the Treatment of Advanced Melanoma
Peking University Cancer Hospital & Institute
Phase NA Unknown
NCT05233358 2022-02-10
HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure
The Central Hospital of Lishui City
Phase NA Unknown
NCT05162898 2022-01-27
Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma.
Henan Cancer Hospital
Phase NA Unknown
NCT04443036 2020-06-23
Clinical Study of Nab-paclitaxel Combined With Toripalimab in Local Advanced or Metastatic G/GEJ Carcinoma
China Medical University, China
Phase NA Unknown